Annemieke also co-chaired a satellited symposium on N-of-1 treatment with antisense oligonucleotides with Takenori Yokota from Tokyo University. Annemieke presented on the Dutch approach to N-of-1 ASO treatment as well as European and global efforts to align N-of-1 ASO development. During the panel session considerations for patient selection and different regulatory aspects in different jurisdictions were discussed.
posted on May 25, 2022
Let us know your questions or suggestions